BGPT: Paper Review: Mechanism of Formin-Induced Nucleation of Actin Filaments

Explore by Goal

Quick Explanation Copied

Core mechanism claim (from the paper):

Bni1 FH1FH2 accelerates actin nucleation most consistently with actin dimer stabilization (modeled as a nucleus of effective size n−1 = 2, i.e., smallest oligomer behaves like an actin dimer), and nucleation rate shows a square-root dependence on nucleator concentration (maximal filament production ∝ √[FH1FH2]).

Long Explanation

Paper Review (Mechanism of Formin-Induced Nucleation of Actin Filaments)

Target paper DOI: https://doi.org/10.1021/bi026520j

Publication date in provided text: 12/17/2002

1) What the paper actually claims (mechanistic map)

Nucleation mechanism (model-based)

FH1FH2-induced nucleation is best fit by a model where the nucleus corresponds to dimer stabilization (smallest oligomer size effectively n−1 = 2, nucleus size parameter discussed as “n=3” for trimer smallest stable oligomer in their notation/model framing).
They interpret this as analogous to other dimer-stabilizing nucleators (they compare to cytochalasin and capping protein behavior within their discussion).

Nucleator concentration scaling

They report maximal polymerization rate increases with FH1FH2 concentration with a square-root dependence (∝ √[FH1FH2]) and also argue this can be a general property of nucleators whose kinetics depend on depletion of free G-actin by filament elongation.

Role of profilin and FH1/FH2 domain functions

They propose FH1 binds profilin, and profilin–FH1 interaction enhances nucleation efficiency when profilin can bind the FH1 polyproline region; a profilin mutant defective in polyproline binding (H133S profilin) fails to enhance nucleation to the extent seen with wild-type profilin.
FH2 partially caps barbed ends: both elongation and depolymerization rates decrease by ~50% while critical concentration is not affected; pointed-end kinetics are reported as unaffected.

Arp2/3 independence in yeast supernatant

They show FH1FH2-induced nucleation/filament formation in yeast high-speed supernatant occurs similarly with and without arp2 (Arp2/3 complex).

2) Visualizations from the paper’s own reported fits / relationships

Figure replica-style plot: maximal polymerization rate vs [FH1FH2] with square-root model

3) Mechanistic consistency checks (skeptical appraisal tied to the authors’ own logic)

3.1 Dimer capture vs sequential addition: underdetermination

The authors explicitly state that the composite constant k_n does not distinguish between capturing a spontaneously formed dimer vs sequential binding of two G-actin monomers, meaning the data-plus-model fitting leaves at least one mechanistic degree of freedom unresolved.
They then argue dimer capture is kinetically inefficient (based on their conservative estimates and the requirement to match observed filament production rates). This is a reasonable argument but still relies on rate-constant assumptions and physical constraints mentioned in their calculation discussion.

3.2 The square-root scaling may not be mechanistically unique

The authors explicitly caution that the square-root dependence can be a general property of nucleators that depend on free G-actin depletion time due to elongation competition; they further mention Arp2/3-induced nucleation follows a similar relationship.

3.3 Partial capping / unchanged critical concentration: mechanistic interpretation limits

They report ~50% inhibition of both elongation and depolymerization with no effect on critical concentration, consistent with partial inhibition of both on and off rates. However, the paper notes that they did not rule out alternative “leaky” cap distributions (e.g., mixture of fully capped vs uncapped ends) and propose multiple “leaky cap” possibilities.

3.4 Yeast supernatant results: “in vivo-like” system but still not the intact cell

The Arp2/3 dependence test is done in yeast high-speed supernatants where endogenous G-actin availability and other modulators may differ from the in-cell cytoplasm; still, they explicitly find that VCA loses activity in arp2-null supernatants while FH1FH2 retains nucleation capacity.

4) Data-to-conclusion map (what supports what?)

Observation (paper text)	Direct mechanistic inference	Evidence strength (within paper)	Skeptical caveat
FH1FH2 polymerization vs G-actin best fit with nucleus size consistent with dimer stabilization	Dimer-stabilizing nucleation model	Strong (best-fit nucleus size)	Composite constant kn not diagnostic of capture vs sequential monomer addition
Max polymerization rate ∝ √[FH1FH2]	Free G-actin depletion coupled to nucleation–elongation kinetics	Strong (reported fit)	Square-root scaling may be general to nucleators, limiting mechanistic specificity
Profilin-actin enhances nucleation when FH1 present; H133S profilin does not	FH1–profilin polyproline interaction contributes to nucleation	Strong (mutant functional test)	Contribution magnitude differs; in vitro contribution can be small relative to in vivo requirement
FH2 partially caps barbed ends: ~50% reduced elongation and depolymerization; critical concentration unchanged	Leaky/partial barbed-end capping with simultaneous on/off inhibition	Strong (multiple kinetic readouts)	Alternative heterogeneous end-state scenarios not fully excluded
FH1FH2 nucleation in yeast supernatant is similar with/without arp2; VCA depends on arp2	Arp2/3-independent nucleation capability of FH1FH2 in extract	Moderate (system-level contrast)	Extract context differs from intact cells; endogenous modulators not fully controlled

Note: Table cells summarize the paper’s own reported logical links; any “caveat” column reflects explicit underdetermination/generalization issues stated in the paper’s Discussion/Results.

5) Reproducibility & missing information (as far as provided text goes)

Methods are fairly detailed in the provided text (construct amino-acid ranges, actin preparation and labeling, nucleation assay approach via pyrenyl fluorescence after dilution, seed types, profilin variants and concentration calibration, and yeast supernatant preparation).
Data availability is not provided in the supplied excerpt (explicit data-availability statement not shown).
Model assumptions are explicitly enumerated in the Appendix for deriving the square-root relationship (e.g., [N] << [G]0; free [G] significantly greater than critical concentration during period; FH1FH2 not significantly consumed). These assumptions bound how fully they can reproduce full time courses vs early/typical regimes.

6) Practical “what would change my mind?” falsification targets

If future experiments show FH1FH2 does not stabilize an actin dimer-like nucleus (i.e., fits that currently prefer n=3/dimer stabilization are replaced by n corresponding to other nucleus sizes) or if independent kinetic observables resolve capture vs sequential addition differently than the paper’s interpretation, the central mechanistic claim would be weakened.
If FH2’s ~50% barbed-end inhibition were later shown not to be “partial capping” (e.g., due to alternative effects on on/off rates unrelated to end accessibility), then the interpretation of leaky capping and its relationship to unchanged critical concentration would change.
If in cellular contexts the Arp2/3 independence observed in supernatants does not hold (e.g., dependence on Arp2/3 varies with cellular state not captured in extracts), then the conclusion about in-cell Arp2/3 independence would need revision.

7) Explore author-centered reviews in BGPT

Feedback:

Updated: April 20, 2026